Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Inventory Average (2016 - 2025)

Historic Inventory Average for Aytu Biopharma (AYTU) over the last 11 years, with Q4 2025 value amounting to $9.4 million.

  • Aytu Biopharma's Inventory Average fell 1782.33% to $9.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $9.4 million, marking a year-over-year decrease of 1782.33%. This contributed to the annual value of $11.8 million for FY2025, which is 232.43% down from last year.
  • According to the latest figures from Q4 2025, Aytu Biopharma's Inventory Average is $9.4 million, which was down 1782.33% from $10.8 million recorded in Q3 2025.
  • In the past 5 years, Aytu Biopharma's Inventory Average ranged from a high of $16.5 million in Q2 2021 and a low of $9.4 million during Q4 2025
  • For the 5-year period, Aytu Biopharma's Inventory Average averaged around $12.8 million, with its median value being $12.6 million (2023).
  • Per our database at Business Quant, Aytu Biopharma's Inventory Average skyrocketed by 26472.13% in 2021 and then tumbled by 2735.74% in 2022.
  • Aytu Biopharma's Inventory Average (Quarter) stood at $16.4 million in 2021, then dropped by 21.45% to $12.9 million in 2022, then rose by 0.57% to $13.0 million in 2023, then decreased by 12.1% to $11.4 million in 2024, then decreased by 17.82% to $9.4 million in 2025.
  • Its last three reported values are $9.4 million in Q4 2025, $10.8 million for Q3 2025, and $11.2 million during Q2 2025.